Metabolic heterogeneity has also been observed between CD133+/CD44+ liver CSCs (LCSCs), derived from the HCCLM3 HCC cell line, and their differentiated counterparts, with the former exhibiting more robust levels of OXPHOS [30]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.